Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia

16/07/2023 8 min Temporada 1 Episodio 1

Ouvir "Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia"

Descargar episodio Ver en sitio original

Sinopse do Episódio

Discussão do artigo "Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia" de Amy E DeZern, publicado Blood. 2023 Jun 22;141(25):3031-3038. doi: 10.1182/blood.2023020435.
Apresentado pelo Dr Diego Luz

Mais episódios do podcast TMO EPM / Hemato H9J

67 - Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma 07/01/2026

66 - Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study 30/12/2025

65 - Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma 05/11/2025

64 - Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin 02/11/2025

63 - Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT 01/09/2025

62 - Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation 10/08/2025

61 - Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study 04/08/2025

60 - Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 27/07/2025

59 - Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation 23/07/2025

58 - Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised,double-blind, placebo controlled, phase 3 study 13/07/2025

Ver todos los episodios